CytoMed Therapeutics GDTC Income Statement (2021-2025)

NASDAQ GDTC
$0.90 +0.00 (+0.00%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2021 Jun2022 Dec2022 Jun2023 Dec2023 Jun2024 Dec2024 Jun2025 Dec2025
Revenue & cost
Cost of Revenue (Quarter) 0.00M0.01M
Revenue (Quarter) 1.30M0.41M
Operating items
Amortization - Intangibles (Quarter) 0.00M321.00
Research & Development (Quarter) 0.60M1.30M-0.36M0.27M
Other Operating Expenses (Quarter) 0.15M0.02M243.00
Operating Expenses (Quarter) 0.60M1.30M-0.36M0.27M
EBIT (Quarter) 0.58M0.56M
Non-operating items
Non Operating Interest Expenses (Quarter) 0.02M0.01M
Non Operating Investment Income (Quarter) -570.00
Other Non Operating Income (Quarter) 0.01M-0.08M-0.21M0.19M
Net income details
EBT (Quarter) 0.58M0.55M
Net Income - Minority (Quarter) 104.00140.00145.000.00M
Tax Provisions (Quarter) 2.76M3.02M
Income towards Parent Company (Quarter) 104.0013.17M10.16M7.15M
Net Income towards Common Stockholders (Quarter) 104.000.59M13.17M11.25M10.16M8.97M7.15M
Profit After Tax (Quarter) -2.18M-2.47M
Income from Continuing Operations (Quarter) -2.18M-2.47M
Consolidated Net Income (Quarter) -2.18M-2.47M
Additional items
EPS (Basic) (Quarter) 0.000.071.661.060.960.780.62
EPS (Diluted) (Quarter) 0.000.071.661.060.960.780.62
Shares Outstanding (Quarter) 6.93M6.93M7.92M7.92M10.63M10.63M11.54M11.54M11.65M
Shares Outstanding (Diluted) (Quarter) 6.93M6.93M7.92M7.92M10.63M10.63M11.54M11.54M11.65M
Shares Outstanding (Entity) (Quarter) 7.48M7.92M11.54M11.54M11.83M
Interest Expenses (Quarter) 0.01M
EBITDA (Quarter) 0.58M0.56M
Tax Rate (Quarter) 475.47%551.25%